Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

NCT06141369 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT06141369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06141369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Phase
Not applicable
Overall status
Recruiting
Start date
January 13, 2024
Completion date
June 30, 2027
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal cortical carcinoma, medullary thyroid cancer, pancreatic neuroendocrine tumor, thymic neuroendocrine carcinoma